A carregar...

Efficacy of Aerosolized Celecoxib Encapsulated Nanostructured Lipid Carrier in Non-small Cell Lung Cancer in combination with Docetaxel

PURPOSE: Evaluation of in-vivo anticancer activity of aerosolized Celecoxib encapsulated Nanolipidcarriers (Cxb-NLC) as a single therapeutic agent and combined with intravenously administered Docetaxel (Doc) against non-small cell lung cancer. METHODS: Cxb-NLC were prepared by high-pressure homogeni...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Patel, Apurva R., Chougule, Mahavir B., Ian, Townley, Patlolla, Ram, Guangdi, Wang, Singh, Mandip
Formato: Artigo
Idioma:Inglês
Publicado em: 2013
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3618607/
https://ncbi.nlm.nih.gov/pubmed/23361589
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11095-013-0984-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!